Literature DB >> 18706704

Undertreatment of osteoporosis following hip fracture in the elderly.

Peter Lüthje1, Ilona Nurmi-Lüthje, Juha-Pekka Kaukonen, Salla Kuurne, Helena Naboulsi, Matti Kataja.   

Abstract

The national Finnish guidelines for medical treatment of hip fracture patients are: osteoporosis medication and the daily concomitant use of vitamin D and calcium supplements. We investigated the post-fracture medical therapy for osteoporosis and the calcium and vitamin D therapy among hip fracture patients in two Finnish hospitals. The pre-fracture osteoporosis medication and use of calcium and vitamin D supplements of the patients were inquired on admission. The patient-specific use of osteoporosis medication and of prescribed calcium and vitamin D therapy during the follow-up time were checked from The Finnish Social Insurance Institution. At the end of the follow-up, those who were alive were inquired about the use of medication at the time. Eight percent of the 223 patients used osteoporosis medication and 8% used prescribed calcium and vitamin D supplements before the fracture. During the follow-up, the figures were 39% (52/133) and 53% (70/133), respectively, and at the end of the follow-up, correspondingly, 25% (29/114) and 44% (50/114). The follow-up time was 19.5-35 months. The post-fracture medical therapy for osteoporosis was insufficient. More effort should be focused on the secondary prevention following hip fracture in order to ensure the recommended treatment of osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706704     DOI: 10.1016/j.archger.2008.06.007

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  15 in total

1.  Hip fracture and other predictors of anti-osteoporosis drug use in Norway.

Authors:  H M Devold; A J Søgaard; A Tverdal; J A Falch; K Furu; H E Meyer
Journal:  Osteoporos Int       Date:  2012-07-10       Impact factor: 4.507

2.  Positive Effects of a Sufficient Pre-fracture Serum Vitamin D Level on the Long-Term Survival of Hip Fracture Patients in Finland: A Minimum 11-Year Follow-Up.

Authors:  Ilona Nurmi-Lüthje; Peter Lüthje; Juha-Pekka Kaukonen; Matti Kataja
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

3.  Do the hospitalized patients with osteoporotic fractures require endocrinologists' help?

Authors:  M Aghamirsalim; R Sorbi
Journal:  J Endocrinol Invest       Date:  2012-09-24       Impact factor: 4.256

4.  Non-linear relationship between serum 25-hydroxyvitamin D concentration and subsequent hip fracture.

Authors:  L de Koning; D Henne; B R Hemmelgarn; P Woods; C Naugler
Journal:  Osteoporos Int       Date:  2012-12-19       Impact factor: 4.507

5.  Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the national health insurance claims data.

Authors:  Hye-Young Kang; Kyu-hyeon Yang; Yoon Nam Kim; Seong-hwan Moon; Won-Jung Choi; Dae Ryong Kang; Seong Eun Park
Journal:  BMC Public Health       Date:  2010-05-04       Impact factor: 3.295

6.  Prevention and clinical management of hip fractures in patients with dementia.

Authors:  Isaura B Menzies; Daniel A Mendelson; Stephen L Kates; Susan M Friedman
Journal:  Geriatr Orthop Surg Rehabil       Date:  2010-11

7.  Orthopedic surgeon's awareness can improve osteoporosis treatment following hip fracture: a prospective cohort study.

Authors:  Sang-Rim Kim; Yong-Chan Ha; Yong-Geun Park; Sung-Rak Lee; Kyung-Hoi Koo
Journal:  J Korean Med Sci       Date:  2011-10-27       Impact factor: 2.153

8.  Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA.

Authors:  A Wilk; S Sajjan; A Modi; C-P S Fan; P Mavros
Journal:  Osteoporos Int       Date:  2014-08-12       Impact factor: 4.507

9.  Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data.

Authors:  M Bonafede; N Shi; R Barron; X Li; D B Crittenden; D Chandler
Journal:  Arch Osteoporos       Date:  2016-07-30       Impact factor: 2.617

10.  Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage.

Authors:  Ethel S Siris; Jingbo Yu; Katalin Bognar; Mitch DeKoven; Anshu Shrestha; John A Romley; Ankita Modi
Journal:  Clin Interv Aging       Date:  2015-11-05       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.